Search results
Richard Lawson on Food and Drug Administration (FDA) | JD Supra
JD Supra· 4 hours agoJD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations. This ...
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with...
NBC 17 Raleigh· 1 hour ago(NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that ...
BrioHealth wins FDA nod to trial BrioVAD ventricular assist device
Clinical Trials Arena via Yahoo Finance· 2 hours agoBrioHealth Solutions has received investigational device exemption (IDE) approval from the US Food ...
FDA approves Boehringer Ingelheim’s Cyltezo for inflammatory ailments
Pharmaceutical Technology via Yahoo Finance· 4 hours agoThe US Food and Drug Administration (FDA) has approved Boehringer Ingelheim's high-concentration ...
CDC, FDA, USDA answer big questions about the growing bird flu outbreak
Phys.org· 2 hours agoRepresentatives with multiple agencies including the CDC, the United States Department of...
Some of the popular weight loss drug Wegovy is back on shelves after a shortage, the FDA says
Quartz· 3 days agoA dose of Wegovy’s highly-coveted weight loss drug is no longer in limited supply, according to Food...
United Imaging secures FDA clearance for uMR Jupiter 5T MRI system
Medical Device Network via Yahoo Finance· 2 hours agoUnited Imaging, a medical imaging and radiotherapy equipment maker, has secured the US Food and Drug...
US FDA approves Neurocrine Biosciences' movement disorder drug (April 30)
Reuters· 2 hours ago, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tuesday. Huntington's disease is an inherited condition ...
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 3 hours agoHowever, the company has many more promising candidates in the hopper. Two of them -- donanemab and mirikuzumab -- already await regulatory approval. The...
Project Optimus: helping or hindering cancer drug development?
Clinical Trials Arena via Yahoo Finance· 4 hours agoAlongside the multitude of guidance documents, recent years have seen the US Food and Drug ...
